Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 121 - 150 of 459
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Albuman 200 g-l infuusioneste, liuos SPC 2021-12-17
PL	Resepti	Albuman 40 g-l infuusioneste, liuos SPC 2021-12-17
PL	Resepti	Albumin Baxalta 200 g-l infuusioneste, liuos SPC 2022-01-14
PL	Resepti	Albumin Baxalta 50 g-l infuusioneste, liuos SPC 2022-01-14
PL	Resepti	Albumin Behring 200 g-l, infuusioneste, liuos SPC 2021-11-23
PL	Resepti	Albunorm 200 g-l infuusioneste, liuos SPC 2022-09-07
PL	Resepti	Albunorm 250 g-l infuusioneste, liuos SPC 2022-09-07
PL	Resepti	Albunorm 40 g-l infuusioneste, liuos SPC 2022-09-07
PL	Resepti	Albunorm 50 g-l infuusioneste, liuos SPC 2022-09-07
PL	Resepti	Alburex 200 g-l infuusioneste, liuos SPC 2021-06-30
PL	Resepti	Alburex 50 g-l infuusioneste, liuos SPC 2023-09-28
PL	Resepti	Albutein 200 g-l infuusioneste, liuos SPC 2023-12-15
PL	Resepti	Albutein 50 g-l infuusioneste, liuos SPC 2023-12-15
		European Medicines Agency's website: Aldara - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Aldurazyme - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Alecensa - EMA: EPAR PI Finnish Swedish
PL	Resepti	Alendronat ratiopharm 70 mg tabletti, kalvopäällysteinen SPC 2023-08-29
PL	Resepti	Alendronat Sandoz 70 mg tabletti SPC 2020-01-22
PL	Resepti	Alendronat Viatris 70 mg tabletti SPC 2024-10-30
PL	Resepti	Alfacalcidol Orifarm 0,25 mikrog, 0,5 mikrog, 1 mikrog kapseli, pehmeä SPC 2022-02-11
PL	Resepti	Alfacalcidol Strides 0,25 mikrog, 0,5 mikrog, 1 mikrog kapseli, pehmeä SPC 2024-01-03
PL	Resepti	Alfentanil Hameln 0.5 mg/ml injektioneste, liuos, SPC 2022-12-12.doc
PL	Resepti	Alfentanil Kalceks 0.5 mg-ml injektio-infuusioneste, liuos SPC 2023-08-23
PL	Resepti	Alfuzosin hydrochlorid ratiopharm 10 mg depottabletti SPC 2024-04-26
PL	Resepti	Alfuzosin hydrochloride Orion 10 mg depottabletti SPC 2023-01-09
		European Medicines Agency's website: ALIMTA - EMA: EPAR PI Finnish Swedish
PL	Resepti	Alitretinoin Orifarm 10 mg, 30 mg kapseli, pehmeä SCP 2020-04-03
PL	Resepti	Alkacit 10 mEq säädellysti vapauttava tabletti SPC 2024-06-12
PL	Resepti	Alkeran 2 mg tabletti, kalvopäällysteinen SPC 2022-06-16
		European Medicines Agency's website: Alkindi - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  |  Next 30   >